Abstract:
Disclosed is a door mirror device that is able to continuously emit light from two light guides. The door mirror device is equipped with a first light-emitting light guide, which is arranged in the visor part of a door mirror that is foldably mounted on the door mirror support part of a vehicle, a second light-emitting light guide, which is arranged in the door mirror support part with continuity so that one end thereof is opposite an end of the first light-emitting light guide, and a light source that shines light toward the first light-emitting light guide and the second light-emitting light guide in the visor part.
Abstract:
Compounds of the following formula are provided for use with kinases: (I) wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.
Abstract:
Compounds of the following formula are provided for use with kinases, wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.
Abstract:
Compounds of the following formula are provided for use with kinases: (I) wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.
Abstract:
The present invention provides PLK inhibitors of the formula (I) wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using the compounds.